The amount of IPO financing on the Science and Technology Innovation Board exceeded 600 billion yuan, with an average of 108 patents per company
Qiao Xiang Ni Ming
In a blink of an eye, the Science and Technology Innovation Board is three years old.
Since the first batch of 25 companies listed on the Science and Technology Innovation Board, more than 400 science and technology companies have set sail and grown here.
Starting from scratch, the total amount of IPO financing on the Science and Technology Innovation Board has exceeded the 600 billion yuan mark; on the way to sail, the total market value of 5.6 trillion yuan marks the engraving of a new "navigation record"; This patent shows the brilliant scientific and technological achievements.
Leading innovation and keeping pace with the times.
Not only is the scale of the "Science and Technology Innovation Corps" steadily increasing, but also in terms of breaking through key core technologies, the Science and Technology Innovation Board has handed over a satisfactory answer sheet.
Looking back at the past three years, the industrial agglomeration and brand effect of the STAR Market have gradually emerged.
The group of companies listed on the Science and Technology Innovation Board, which is highly focused on high-tech industries and strategic emerging industries, plays an increasingly prominent role in serving national strategies and promoting high-quality economic development.
The Science and Technology Innovation Board adheres to the positioning of the board, highlights the "hard words in the first place", focuses on supporting key core technology innovation, and implements the concept of "hard technology" to the end.
Steady expansion: the effect of industrial agglomeration gradually emerges
Focusing on "hard technology" companies is the orientation and initial intention of the Sci-Tech Innovation Board.
In this context, the Science and Technology Innovation Board focuses on supporting high-tech industries and strategic emerging industries such as new generation information technology, high-end equipment, new materials, new energy, energy conservation and environmental protection, and biomedicine.
As of the end of June 2022, a total of 147 new-generation information technology companies, 97 high-end equipment companies, 93 biopharmaceutical companies, 39 new material companies, 31 energy conservation and environmental protection companies, and 24 new energy companies have been listed on the Science and Technology Innovation Board.
Behind the numbers is the gradual emergence of industry agglomeration and brand effects on the Science and Technology Innovation Board.
In a number of "hard technology" fields oriented to the frontier of science and technology, the Science and Technology Innovation Board has brought together a group of innovative companies involving various links in the industrial chain and multiple application scenarios, promoting the improvement of the independent and controllable capabilities of the industrial chain and supply chain.
As of the end of June 2022, the number of companies in the integrated circuit field of the Science and Technology Innovation Board has reached 61, accounting for "half of the country" of A-share listed integrated circuit companies. We will continue to deepen the innovation chain and improve the supply chain.
As one of the few IDM integrated industry chain companies in China, China Resources Micro said that in the future, it will focus on its core advantages, continue to deepen the industry chain, strive to improve core technology innovation capabilities, and combine internal and external resources to further develop into a comprehensive and integrated company. transformation.
In order to create internationally competitive products, China Micro Corporation, which is deeply involved in the field of chip manufacturing and etching, has laid out a diversified product line.
The reporter from China Securities News learned from the company that in the manufacturing of logic integrated circuits, the company is developing more advanced etching application equipment according to the needs of customers.
In addition, the company has worked closely with many first-class LED epitaxial wafer manufacturers to achieve deep industrial integration.
In the field of biomedicine, the total number of companies listed on the Science and Technology Innovation Board has reached 93, covering the treatment fields of cancer, AIDS, hepatitis B, hepatitis C, chickenpox and other diseases.
Upstream and downstream enterprises in the industrial chain such as photovoltaics, power batteries, and industrial robots are also landing on the Science and Technology Innovation Board.
In a number of "hard technology" fields facing the frontier of science and technology, a group of key technology researchers are leveraging the capital market to realize the deep integration of innovation chain, industrial chain, talent chain and capital chain.
Follow the original intention and observe the results.
"Good news" at the patent level continues to emerge.
In 2021, more than 7,800 new invention patents will be added by companies on the Sci-Tech Innovation Board, and projects led or participated by 66 sub-companys have won major awards such as the National Science and Technology Award.
Among them, Anji Technology's chemical mechanical polishing liquid products, Tianyue advanced semi-insulating silicon carbide substrate materials, a full range of high-reliability IGBT products from Times Electric, and Kede CNC five-axis linkage CNC machine tools have broken the foreign monopoly situation. Realize domestic independent supply, provide strong support for the independent control of related industrial chains, and demonstrate the technical strength and mission of "hard technology" enterprises.
R&D solid foundation: "hard technology" is further highlighted
Nothing can be achieved without hard work, and nothing can be achieved without innovation.
For scientific and technological innovation-oriented companies, R&D innovation is the foundation of survival.
In the past year, the R&D intensity of companies listed on the Science and Technology Innovation Board has remained high.
By the end of 2021, the total amount of R&D investment by companies on the Science and Technology Innovation Board reached 88.351 billion yuan, a year-on-year increase of 31%, and R&D investment accounted for 13% of operating income.
During the interview with reporters, the interviewed companies have a very clear attitude towards continuous investment in R&D.
"The company attaches great importance to R&D and innovation, and will continue to invest heavily in R&D." The relevant person in charge of Aojie Technology-U told reporters.
"Since the company's listing on the Science and Technology Innovation Board, the company's operating income has continued to grow rapidly, and the company has continued to maintain high investment in research and development." Wu Yunkun, president of Qi'anxin-U, said, especially in the platform research and development related to the company's future development, the investment will be greater. The technical strength will be further improved.
From a long-term perspective, continuous R&D investment is the only way for science and technology companies to make breakthroughs in core technologies.
In fact, most of the companies on the Sci-Tech Innovation Board that have made great progress in their respective fields have continued to increase their investment in the layout and research of cutting-edge technologies, and innovative achievements have emerged one after another.
In 2021, photovoltaic product manufacturer JinkoSolar will invest 2.637 billion yuan in research and development, accounting for 6.5% of its revenue.
In terms of technological breakthroughs, the company has broken the industry mass production or laboratory test records 19 times in terms of cell conversion efficiency and module power, and has broken world records 4 times within a year in the field of N-type TOPCon.
According to the relevant person in charge of the company, the company has reserved technologies with good development prospects, such as Czochralski single crystal charging outside the furnace.
Kasai Bio, which is engaged in the research and development of new bio-based materials, actively enhances "brain power".
The relevant person in charge of the company revealed to reporters that the company's annual production of 40,000 tons of biological sebacic acid in the commissioning stage is the first time in the world to use biological methods to produce sebacic acid products, and it is the first industrialized biological method 20 years ago. Since the chain dibasic acid has further enriched the long-chain dibasic acid product categories.
Shanghai Silicon Industry-U, a semiconductor silicon wafer enterprise that regards innovation as the first driving force for development, has successfully solved the "presence or absence" of SOI materials in my country and achieved a "zero" breakthrough in the industrialization of 300mm large silicon wafers.
At present, the company's 300mm products have achieved full coverage of the needs of major domestic customers.
As an important indicator to measure the quality of "hard technology", as of June 30, 2022, a total of 141 companies listed on the Science and Technology Innovation Board have been selected into the national directory of "little giants", accounting for 10% of the total number of companies listed on the Science and Technology Innovation Board. 32.7%, and 35.7% of the total number of listed companies specializing in new "little giants".
Talent "Peiyuan": Establishing a Long-term Incentive Mechanism
The "hard technology" industry is inseparable from the support of talents.
So far, the Sci-Tech Innovation Board has gathered a scientific research team of more than 140,000 people, with an average of more than 330 people per company, accounting for nearly 30% of the total number of employees.
According to industry insiders, semiconductors and other high-tech industries are capital-intensive and technology-intensive industries, and have the characteristics of extensive downstream applications, many production technology processes, many product types, rapid technological upgrading, high investment, and high risks. Experienced talents are the key to the future development of such companies and an important factor to continuously consolidate the company's core competitiveness.
According to Wind statistics, as of the end of last year, there were 24 Sci-Tech Innovation Board companies with more than 1,000 R&D personnel, 9 of which had more than 2,000 employees. CRSC ranked first with 4,374 R&D personnel.
From the perspective of the proportion of R&D personnel, among the 137 STAR Market companies with more than 300 R&D personnel, 32 companies have R&D personnel accounting for more than 50% of the total employees.
Among them, 9 companies accounted for more than 80%, and Aojie Technology-U ranked first with 89.35%.
Emphasis on talents, Gaolun Electronics, which focuses on the independent design and research and development of EDA tools, has a lot of experience.
According to the relevant person in charge of the company, a large proportion of the company's R&D personnel hold the company's shares.
"This move is intended to enhance the enthusiasm and cohesion of R&D personnel. After the company is listed on the Science and Technology Innovation Board, its attraction to outstanding talents in the industry will be further strengthened. In the future, the company will adopt various methods including equity incentives to further attract And retain talent.”
There are not a few companies on the science and technology board that understand this.
Qi Anxin-U recently announced the draft equity incentive plan, which intends to further bind the company's technical backbone and steadily promote the talent strategy.
On the establishment of a long-term incentive mechanism, Zhenhua New Materials said that in the future, it will make full use of the flexible equity incentive system of the Science and Technology Innovation Board, and further implement a wider range of equity incentive plans to better unite people, inspire employee morale, and stimulate Employee identity and sense of belonging.
The establishment of long-term incentive systems such as employee stock ownership platforms and stock options has also become a measure for biopharmaceutical companies to retain talents.
Junshi Bio-U stated that the Science and Technology Innovation Board has relaxed the restrictions on equity incentives, allowing companies to "list with rights". After the company is listed, it adopts the second type of restricted stock plan launched by the Science and Technology Innovation Board to grow and achieve mutual success with employees. , greatly improving the company's ability to attract and retain talents, and provide intellectual support for innovative research and development.
Heyuan Biology revealed that it is currently preparing talents for the gene therapy CDMO business line through internal training and external introduction.
At the same time, the company plans to reserve a sufficient process team for the future large-scale GMP production operation, continue to enrich the R&D team, and introduce high-end excellent technical talents.